“We are enormously gratified to welcome Dr. Cunningham to the Actinium Pharmaceuticals team,” said Kaushik J. Dave, Ph.D, Actinium’s Chief Executive Officer.
Rosenbaum, et al are spending their own money to oust an incompetent BOD and CEO, whereas NP is spending shareholders money to keep his job. Spending millions to KEEP a failure, thief and liar. AMAZING!
SEC and DOJ may ultimately have some say in the matter. NP will look fetching in an orange jumpsuit.
More hot water as CYDY filed a False and misleading 8K about 13D group with SEC.
News 
Market Data 
Discover 
AI
